Researchers develop innovative vascularized tumor model to advance cancer immunotherapy

A research team led by the Faculty of Dentistry at The University of Hong Kong (HKU) has developed a novel vascularized tumor model using a non-surgical injectable hydrogel system. This innovative approach provides a powerful new platform for researching cancer and testing immune cell therapies. The breakthrough has been published in Advanced Composites and Hybrid Materials and represents a significant advancement in modeling the complex nature of tumors for oncology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup